Background Hepatitis B is an important public health issue, especially in the female prison population. The high prevalence in this population is largely accounted for by the high rates of injecting drug use and the fact that these women are more likely to exchange sex for drugs or money and practice unprotected sex. There is a national programme in English prisons to vaccinate everyone against Hepatitis B. This study aimed to investigate whether women who had been in prison before were more likely to have been vaccinated against hepatitis B and whether contact with community services was more likely to predict hepatitis B vaccination. Methods A questionnaire survey of new entrants into two women’s prisons in England. Results Four hundred a...
Abstract Objectives: Testing is the first step in treatment and care for blood‐borne viruses (BBVs) ...
Background: Targeted vaccination strategies are necessary to prevent people who use drugs (PWUD) bec...
Background: The prevalence of isolated hepatitis B core antibody (anti-HBc) varies between 1% and 30...
Background: Hepatitis B is an important public health issue, especially in the female prison populat...
BACKGROUND: Hepatitis B is an important public health issue, especially in the female prison populat...
Objectives: To determine the prevalence of antibodies to hepatitis B core antigen, hepatitis C virus...
Objectives: Testing is the first step in treatment and care for blood-borne viruses (BBVs) and sexua...
INTRODUCTION: Little information regarding hepatitis B virus (HBV) and hepatitis C virus (HCV) ...
In 1999, the Department of Health allocated additional funding to Health Authorities in England to e...
Summary: Background and aim: Prisons in Egypt do not currently screen for blood-borne viruses, and ...
Background: Identification and knowledge of settings with high prevalence of hepatitis C virus (HCV)...
Background: Prevalence data on viral hepatitis B (HBV), hepatitis C (HCV), and HIV infection in pris...
A vaccination programme offering hepatitis B (HBV) vaccine at reception into prison has been introdu...
The objectives of this study were to determine the prevalence of antibodies to hepatitis B core anti...
Objective: Determine the incidence of hepatitis C virus antibodies among a cohort of prisoners. Desi...
Abstract Objectives: Testing is the first step in treatment and care for blood‐borne viruses (BBVs) ...
Background: Targeted vaccination strategies are necessary to prevent people who use drugs (PWUD) bec...
Background: The prevalence of isolated hepatitis B core antibody (anti-HBc) varies between 1% and 30...
Background: Hepatitis B is an important public health issue, especially in the female prison populat...
BACKGROUND: Hepatitis B is an important public health issue, especially in the female prison populat...
Objectives: To determine the prevalence of antibodies to hepatitis B core antigen, hepatitis C virus...
Objectives: Testing is the first step in treatment and care for blood-borne viruses (BBVs) and sexua...
INTRODUCTION: Little information regarding hepatitis B virus (HBV) and hepatitis C virus (HCV) ...
In 1999, the Department of Health allocated additional funding to Health Authorities in England to e...
Summary: Background and aim: Prisons in Egypt do not currently screen for blood-borne viruses, and ...
Background: Identification and knowledge of settings with high prevalence of hepatitis C virus (HCV)...
Background: Prevalence data on viral hepatitis B (HBV), hepatitis C (HCV), and HIV infection in pris...
A vaccination programme offering hepatitis B (HBV) vaccine at reception into prison has been introdu...
The objectives of this study were to determine the prevalence of antibodies to hepatitis B core anti...
Objective: Determine the incidence of hepatitis C virus antibodies among a cohort of prisoners. Desi...
Abstract Objectives: Testing is the first step in treatment and care for blood‐borne viruses (BBVs) ...
Background: Targeted vaccination strategies are necessary to prevent people who use drugs (PWUD) bec...
Background: The prevalence of isolated hepatitis B core antibody (anti-HBc) varies between 1% and 30...